GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » Additional Paid-In Capital

SLS BIO Co (XKRX:246250) Additional Paid-In Capital : ₩5,155 Mil(As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co Additional Paid-In Capital?


SLS BIO Co's quarterly additional paid-in capital increased from Sep. 2023 (₩202 Mil) to Dec. 2023 (₩5,155 Mil) but then stayed the same from Dec. 2023 (₩5,155 Mil) to Mar. 2024 (₩5,155 Mil).

SLS BIO Co's annual additional paid-in capital stayed the same from Dec. 2021 (₩202 Mil) to Dec. 2022 (₩202 Mil) but then increased from Dec. 2022 (₩202 Mil) to Dec. 2023 (₩5,155 Mil).


SLS BIO Co Additional Paid-In Capital Historical Data

The historical data trend for SLS BIO Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co Additional Paid-In Capital Chart

SLS BIO Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only 9,801.58 287.53 201.80 201.80 5,154.86

SLS BIO Co Quarterly Data
Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial - 201.80 201.80 5,154.86 5,154.86

SLS BIO Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

SLS BIO Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of SLS BIO Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


SLS BIO Co (XKRX:246250) Business Description

Traded in Other Exchanges
N/A
Address
Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229
SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co (XKRX:246250) Headlines

No Headlines